Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening

January 16, 2015 updated by: Kara Hoppe, University of Washington

Randomized Controlled Trial: Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening

The purpose of this study is to perform a randomized controlled trial to compare the efficacy of 80mL double balloon catheter versus a 30mL single catheter balloon for pre-induction cervical ripening by evaluating the change in Bishop score.

Study Overview

Study Type

Interventional

Enrollment (Actual)

105

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Bishop score of 5 or less
  • Singleton
  • Cephalic presentation
  • Fewer than 4 contractions in 10 minutes
  • Reactive fetal monitoring

Exclusion Criteria:

  • Non-vertex presentation
  • Placenta previa
  • Vasa previa
  • Unexplained vaginal bleeding
  • Active herpes simplex virus infection
  • Non-English speaking
  • Previous attempt at an induction of labor in the current pregnancy
  • Prolapsed umbilical cord
  • More than one prior cesarean delivery or history of classical cesarean delivery
  • Patients receiving or planning to undergo exogenous prostaglandin administration as the primary induction agent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 80mL double balloon catheter (Cook catheter®)
The balloon catheters have been used to provide mechanical dilation to the cervix as a method of pre-induction cervical ripening.
Active Comparator: 30mL single Foley balloon catheter
The balloon catheters have been used to provide mechanical dilation to the cervix as a method of pre-induction cervical ripening.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Bishop score greater than or equal to 6 at time of balloon catheter removal
Time Frame: until catheter removal (12 hours maximum)
until catheter removal (12 hours maximum)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
induction to delivery time
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
vaginal delivery time less than 24 hours from initiation of induction
Time Frame: 24 hours
24 hours
mode of delivery
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Time to catheter expulsion
Time Frame: Up to 12 hours
Up to 12 hours
Type of catheter expulsion
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
spontaneous vs. provider
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Epidural utilization
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Meconium stained amniotic fluid
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
5 minute Apgar score
Time Frame: The participants infant will be monitored from immediately to 5 minutes after birth
The participants infant will be monitored from immediately to 5 minutes after birth
Medication required to augment labor
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
prostaglandins, oxytocin
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Artificial rupture of membranes required to augment labor
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Cesarean section indications
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Neonatal intensive care unit admissions
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
Chorioamnionitis
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
birthweight
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kara K Hoppe, DO, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

November 1, 2013

Study Completion (Actual)

November 1, 2013

Study Registration Dates

First Submitted

December 1, 2014

First Submitted That Met QC Criteria

January 16, 2015

First Posted (Estimate)

January 26, 2015

Study Record Updates

Last Update Posted (Estimate)

January 26, 2015

Last Update Submitted That Met QC Criteria

January 16, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 36685-D

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pre-induction Cervical Ripening

Clinical Trials on mechanical pre-induction cervical ripening

Subscribe